Literature DB >> 4322038

Effet of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3':5'-cyclic monophosphate.

G Ball, G G Brereton, M Fulwood, D M Ireland, P Yates.   

Abstract

1. Human platelet nucleotides were labelled by incubating platelet-rich plasma with [U-(14)C]adenine. With such platelets, the effects of prostaglandin E1, theophylline and aspirin were determined on collagen-induced platelet aggregation and release of platelet ATP and ADP. Intracellular changes of platelet radioactive nucleotides, particularly 3':5'-cyclic AMP, were also determined both with and without collagen treatment. 2. Prostaglandin E1, theophylline and aspirin inhibited collagen-induced aggregation of platelets in a dose-dependent manner. Collagen-induced release of ATP and ADP and breakdown of radioactive ATP were also inhibited in a dose-dependent manner. 3. Prostaglandin E1 stimulated the formation of platelet radioactive 3':5'-cyclic AMP in a dose-dependent manner. With a given dose of prostaglandin E1, maximum formation of radioactive 3':5'-cyclic AMP occurred by 10-30s and thereafter the concentrations declined. The degree of inhibition of aggregation produced by prostaglandin E1, however, increased with its time of incubation in platelet-rich plasma before addition of collagen, so that there was an inverse relationship between the radioactive 3':5'-cyclic AMP concentration measured at the time of collagen addition and the subsequent degree of inhibition of aggregation obtained. 4. Neither theophylline nor aspirin at a concentration in platelet-rich plasma of 1.7mm altered platelet radioactive 3':5'-cyclic AMP contents. In the presence of prostaglandin E1, theophylline increased the concentration of radioactive 3':5'-cyclic AMP over that noted with prostaglandin E1 alone, but aspirin did not. 5. Mixtures of prostaglandin E1 and theophylline had a synergistic effect on inhibition of platelet aggregation. The same was true to a lesser extent with mixtures of prostaglandin E1 and aspirin. Such mixtures also inhibited collagen-induced release of platelet ATP and ADP and breakdown of platelet radioactive ATP. 6. Certain concentrations of either theophylline or aspirin and mixtures of small concentrations of prostaglandin E1 with either theophylline or aspirin caused little or no increase of radioactive 3':5'-cyclic AMP at the time of collagen addition, but inhibited aggregation to a marked degree, whereas higher concentrations of prostaglandin E1 alone caused a much greater increase of radioactive 3':5'-cyclic AMP at the time of collagen addition but inhibited aggregation to a lesser extent. With these compounds there does not appear to be a correlation between these parameters.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4322038      PMCID: PMC1179663          DOI: 10.1042/bj1200709

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  14 in total

1.  Platelet aggregation. I. Regulation by cyclic AMP and prostaglandin E1.

Authors:  N R Marquis; R L Vigdahl; P A Tavormina
Journal:  Biochem Biophys Res Commun       Date:  1969-09-10       Impact factor: 3.575

2.  A simple, sensitive method for the assay of adenyl cyclase.

Authors:  G Krishna; B Weiss; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1968-10       Impact factor: 4.030

3.  Effects of salicylates on human platelets.

Authors:  J R O'Brien
Journal:  Lancet       Date:  1968-04-13       Impact factor: 79.321

4.  Inhibition and reversal of platelet aggregation by methyl xanthines.

Authors:  N G Ardlie; G Glew; B G Schultz; C J Schwartz
Journal:  Thromb Diath Haemorrh       Date:  1967-12-31

5.  Effect of some inhibitors of platelet aggregation on platelet nucleotides.

Authors:  G Ball; M Fulwood; D M Ireland; P Yates
Journal:  Biochem J       Date:  1969-09       Impact factor: 3.857

6.  Effect of prostaglandin E1 on platelet behaviour in vitro and in vivo.

Authors:  P R Emmons; J R Hampton; M J Harrison; A J Honour; J R Mitchell
Journal:  Br Med J       Date:  1967-05-20

7.  Detection and determination of adenosine diphosphate and related substances in plasma.

Authors:  D M Ireland; D C Mills
Journal:  Biochem J       Date:  1966-05       Impact factor: 3.857

8.  Microdetermination of adenosine diphosphate and adenosine triphosphate in plasma with firefly luciferase system.

Authors:  H Holmsen; I Holmsen; A Bernhardsen
Journal:  Anal Biochem       Date:  1966-12       Impact factor: 3.365

9.  Effects of adrenaline on human blood platelets.

Authors:  D C Mills; G C Roberts
Journal:  J Physiol       Date:  1967-11       Impact factor: 5.182

10.  The effect of acetylsalicyclic acid on platelet function.

Authors:  G Evans; M A Packham; E E Nishizawa; J F Mustard; E A Murphy
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  15 in total

1.  Cyclic AMP of blood platelets: accumulation in organelles storing 5-hydroxytryptamine and ATP.

Authors:  M da Prada; W P Burkard; A Pletscher
Journal:  Experientia       Date:  1972-07-15

2.  Demonstration of adenosin 3',5'-monophosphate dependent protein-phosphokinase in human platelets.

Authors:  H D Kaulen; R Gross
Journal:  Klin Wochenschr       Date:  1972-12-01

3.  Effects of catecholamines on the formation of adenosine 3':5'-cyclic monophosphate in human blood platelets.

Authors:  R J Haslam; A Taylor
Journal:  Biochem J       Date:  1971-11       Impact factor: 3.857

Review 4.  Platelets, thrombosis and drugs.

Authors:  J F Mustard; M A Packham
Journal:  Drugs       Date:  1975       Impact factor: 9.546

5.  Thrombin-induced increase in intracellular cyclic 3',5'-adenosine monophosphate in human platelets.

Authors:  M J Droller; S M Wolfe
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

6.  Regulation of platelet glycoprotein IIb/IIIa (integrin alpha IIB beta 3) function via the thrombin receptor.

Authors:  A N Giesberts; G van Willigen; E G Lapetina; J W Akkerman
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

7.  Theophylline inhibits platelet aggregation, prostaglandin and thromboxane production by a mechanism which is independent of cyclic AMP.

Authors:  G B Burns; J A Dodge
Journal:  Agents Actions       Date:  1984-01

8.  13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor.

Authors:  G C Le Breton; D L Venton; S E Enke; P V Halushka
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

9.  Daphnoretin, a new protein kinase C activator isolated from Wikstroemia indica C.A. Mey.

Authors:  F N Ko; Y L Chang; Y H Kuo; Y L Lin; C M Teng
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

10.  Inhibition of primary ADP-induced platelet aggregation in normal subjects after administration of nitrofurantoin (furadantin).

Authors:  E C Rossi; N W Levin
Journal:  J Clin Invest       Date:  1973-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.